The burden of illness of cancer: Economic cost and quality of life

被引:199
作者
Brown, ML [1 ]
Lipscomb, J [1 ]
Snyder, C [1 ]
机构
[1] NCI, Appl Res Program, Div Canc Control & Populat Sci, Bethesda, MD 20892 USA
关键词
QALYs; DALYs; incidence; prevalence; HRQOL;
D O I
10.1146/annurev.publhealth.22.1.91
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Cancer is a major public health issue and represents a significant burden of disease. In this chapter, we analyze the main measures of burden of disease as relate to cancer. Specifically, we review incidence and mortality, years of Life lost from cancer, and cancer prevalence. We also discuss the economic burden of cancer, including cost of illness, phase-specific and long-term costs, and indirect costs. We then examine the impact of cancer on health-related quality of life as measured in global terms (disability-adjusted life years and quality-adjusted life years) and using evaluation-oriented applications of health-related quality of life scales. Throughout, we note the relative strengths and weaknesses of the various approaches to measuring the burden of cancer as well as the methodologic challenges that persist in burden-of-illness research. We conclude with a discussion of the research agenda to improve our understanding of the burden of cancer and of illness more generally.
引用
收藏
页码:91 / 113
页数:23
相关论文
共 42 条
  • [1] American Cancer Society, 2000, CANC FACTS FIG
  • [2] [Anonymous], 1998, SCI OPP PUBL NEEDS I
  • [3] [Anonymous], 2000, World Health Report 2000: Health Systems: Improving Performance
  • [4] Baily MN, 1997, BROOKINGS PAP ECO AC, P143
  • [5] BRADLEY CJ, 2001, CANC NURSING PRINCIP
  • [6] Obtaining long-term disease specific costs of care - Application to Medicare enrollees diagnosed with colorectal cancer
    Brown, ML
    Riley, GF
    Potosky, AL
    Etzioni, RD
    [J]. MEDICAL CARE, 1999, 37 (12) : 1249 - 1259
  • [7] BROWN ML, 1996, CANC EPIDEMIOLOGY PR, P255
  • [8] Cella D. F, 1996, QUALITY LIFE PHARMAC, P203
  • [9] Quality of life in oncology practice: Prognostic value of EORTC QLQ-C30 scores in patients with advanced malignancy
    Coates, A
    Porzsolt, F
    Osoba, D
    [J]. EUROPEAN JOURNAL OF CANCER, 1997, 33 (07) : 1025 - 1030
  • [10] Cohodes D R, 1982, Eval Health Prof, V5, P381, DOI 10.1177/016327878200500402